---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-089074"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T23:14:07.235732+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MedTech Acquisition shareholders approve TriSalus merger; $9.4M redeemed

## Summary
- All 14 proposals approved by >99% of votes cast at August 8 special meeting.
- Holders of 890,499 Class A shares elected redemption for ~$9.42M ($10.58/share) from trust.
- Business combination with TriSalus expected to close subject to conditions.
- Combined company securities to trade on Nasdaq under symbols TLSI (common) and TLSIW (warrants).
- Adjournment proposal not presented due to sufficient votes for all proposals.

## SEC filing metadata
- accession: 0001104659-23-089074
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/tm2323269d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-089074
- JSON: https://secwatch.observer/filing/0001104659-23-089074.json
- Plain text: https://secwatch.observer/filing/0001104659-23-089074.txt

## Key facts
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3A at the 2023-08-08 meeting.
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 3A. Governance Proposal 3A : For Against Abstain 7,134,005 20,016 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved The Charter Approval Proposal at the 2023-08-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 2. The Charter Approval Proposal : i. Class A Common Stock For Against Abstain 7,135,004 19,016 0 ii. Class B Common Stock For Against Abstain 1 0 0 iii. Total Common Stock For Against Abstain 7,135,005 19,016 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved The Nasdaq Proposal at the 2023-08-08 meeting.
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 6. The Nasdaq Proposal : For Against Abstain 7,135,005 19,016 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3D at the 2023-08-08 meeting.
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 3D. Governance Proposal 3D : For Against Abstain 7,135,005 19,016 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved Director Nomination Proposal B at the 2023-08-08 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 7B. Director Nomination Proposal B : i. David J. Matlin For Withheld 7,135,005 19,016
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3C at the 2023-08-08 meeting.
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 3C. Governance Proposal 3C : For Against Abstain 7,135,005 19,016 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved The Business Combination Proposal at the 2023-08-08 meeting.
  - Proposal: merger approval
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 1. The Business Combination Proposal : For Against Abstain 7,135,003 19,016 2
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3B at the 2023-08-08 meeting.
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 3B. Governance Proposal 3B : For Against Abstain 7,135,005 19,016 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved The Stock Plan Proposal at the 2023-08-08 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 4. The Stock Plan Proposal : For Against Abstain 7,135,000 19,021 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved Governance Proposal 3E at the 2023-08-08 meeting.
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 3E. Governance Proposal 3E : For Against Abstain 7,135,005 19,016 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved The ESPP Proposal at the 2023-08-08 meeting.
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 5. The ESPP Proposal : For Against Abstain 7,135,000 19,021 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved Director Nomination Proposal A at the 2023-08-08 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-08-08
  source text: 7A. Director Nomination Proposal A : i. Anil Singhal For Withheld 7,135,005 19,016
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923089074/0001104659-23-089074-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
